BUY BOROSIL RENEWABLES LIMITED — Shrikant Chouhan, Kotak Securities
byShrikant Chouhan, Kotak SecuritiesHorizon: NA (inferred 1–3 months)16 Sept 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·7 Nov · today
1 advisor has an active long-term BUY call on this stock
Advisor consensus · adjacent horizon·17 Sept · 2mo ago
The company reported unaudited financial results for the quarter and half year ended September 30, 2026, and announced amendments to its ESOS 2017 scheme and an extension for utilizing preferential is
NSE · Outcome of Board Meeting·30 Oct · 1w ago
The company reported unaudited financial results for the quarter and half year ended September 30, 2026, approved amendments to its ESOS 2017 scheme, and extended the timeline for utilizing preferenti
BSE · Board Meeting·30 Oct · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on BOROSIL RENEWABLES
- BUY — Vinay Rajani, HDFC Securities25 Sept 2026 · ~2 weeks · target ₹490 · SL hit
- BUY — Ambareesh Baliga17 Sept 2026 · ~1 year · target ₹580 · Active
- BUY — Prashant P. Sawant12 Aug 2026 · ~2 weeks · target ₹595 · SL hit
- BUY — Sandeep Jain, Tradeswift30 Jul 2026 · ~3 months · target ₹670 · Expired
- BUY — Nilesh Jain, Centrum Broking13 Jul 2026 · ~2 weeks · target ₹675 · SL hit
More from Shrikant Chouhan, Kotak Securities
- BUY State Bank of India6 Nov 2026 · Same day · target ₹1,030 · Expired
- BUY Piramal Pharma6 Nov 2026 · ~2 weeks · target ₹250 · Active
- BUY Union Bank of India5 Nov 2026 · Next day · target ₹205 · Active
- BUY Maruti Suzuki India5 Nov 2026 · ~2 weeks · target ₹12,500 · Target hit
- BUY Dr. Lal Path Labs5 Nov 2026 · ~2 weeks · target ₹2,150 · SL hit

